Work

LETTER TO THE EDITOR Abnormal Responses of Keloid Tissue to Wounding Identified Using In Vitro Model System.

Year: 2012
Type: letter
Abstract: Keloids are thick, raised scars that represent an extreme form of abnormal scarring. Unlike normal scars, keloids extend beyond the original wound margin and rarely regress; instead, they tend to proliferate indefinitely. 1-4 These bulky scars can significantly impair function due to itching, pain, and decreased range of motion 5 and can negatively impact psychosocial well-being and overall quality of life. 5-7 Although many different therapeutic modalities exist, keloids are extremely resistant to treatment and have a high rate of recurrence. 1,2,8-10 Development of effective, targeted interventions has been limited due to an incomplete understanding of the pathophysiology of keloid scarring. Furthermore, because keloid scarring is only found in humans, there are no animal models of keloid scarring, which has hindered the evaluation of novel therapies. Ethical considerations preclude wound healing studies in patients susceptible to keloid scarring. Therefore, in the absence of suitable animal models, organotypic models represent a feasible alternative for investigation of wounding in keloid tissue. In the current study, we investigated engineered skin substitutes (ESS) composed of keratinocytes, fibroblasts, and collagen-glycosaminoglycan biopolymers, as an in vitro organotypic keloid model to analyze changes in gene expression
Language: English
Subfield: Dermatology
Field: Medicine
Open Access status: green
OpenAlex ID: W227864382
Cites: 22
Cited by: 6
Related to: 10